The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry (Q42983207)

12 November 2017

The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry (English)

1 reference

12 November 2017

0 references

1 reference

9

Philippe Desprès

1 reference

12 November 2017

5

Christian Drosten

1 reference

12 November 2017

2

Sylvie Paulous

1 reference

12 November 2017

6

Beate M Kümmerer

1 reference

12 November 2017

8

Valérie Caro

1 reference

12 November 2017

Hans Henrik Gad

1

1 reference

12 November 2017

Essia Belarbi

series ordinal

3

1 reference

12 November 2017

Laure Diancourt

series ordinal

4

1 reference

12 November 2017

Aileen E Plate

series ordinal

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

11 August 2012

1 reference

12 November 2017

1 reference

12 November 2017

434

1 reference

12 November 2017

27-37

1 reference

12 November 2017

1

1 reference

Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Arbovirus high fidelity variant loses fitness in mosquitoes and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya Virus and Aedes Mosquitoes: Saliva Is Infectious as soon as Two Days after Oral Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya virus, southeastern France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Alphavirus Entry and Membrane Fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Importance of eIF2alpha phosphorylation and stress granule assembly in alphavirus translation regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Human muscle satellite cells as targets of Chikungunya virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Biology and pathogenesis of chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Replication cycle of chikungunya: a re-emerging arbovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Characterization of reemerging chikungunya virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Investigations of combinations of mutations in the jellyfish green fluorescent protein (GFP) that afford brighter fluorescence, and use of a version (VisGreen) in plant, bacterial, and animal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Sindbis viral vector induced apoptosis requires translational inhibition and signaling through Mcl-1 and Bak.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Identification and characterization of interferon-induced proteins that inhibit alphavirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.07.019

10.1016/J.VIROL.2012.07.019

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference